The partnership aims to enhance manufacturing of extracellular vesicles (EVs) using continuous bioprocessing technologies to make regenerative medicine cheaper. The aim of the collaboration is to deliver exosome manufacture, using Univercells’ scale-X hydro fixed-bed bioreactor and RoosterBio’s human mesenchymal stem/stromal cells (hMSC) bioprocess and engineering media systems to establish EV produ ction. “A first step will be to evaluate the performance of the EV manufacturing process in the scale-X bioreactor and benchmarking it against a reference process (microcarriers process in the…